This book is a whole lot of fun. It has a lot of spells and witchcraft. It will keep you on a roller-coaster ride from the beginning to the end and will make you want more. It will open your eyes to a lot of magic. This book is for everyone to enjoy.
This book is a whole lot of fun. It has a lot of spells and witchcraft. It will keep you on a roller-coaster ride from the beginning to the end and will make you want more. It will open your eyes to a lot of magic. This book is for everyone to enjoy.
A look inside the personal life of every first lady in American history, based on original interviews with major historians C-SPAN's yearlong history series, First Ladies: Influence and Image, featured interviews with more than fifty preeminent historians and biographers. In this informative book, these experts paint intimate portraits of all forty-five first ladies -- their lives, ambitions, and unique partnerships with their presidential spouses. Susan Swain and the C-SPAN team elicit the details that made these women who they were: how Martha Washington intentionally set the standards followed by first ladies for the next century; how Edith Wilson was complicit in the cover-up when President Wilson became incapacitated after a stroke; and how Mamie Eisenhower used the new medium of television to reinforce her, and her husband's, positive public images. This book provides an up-close historical look at these fascinating women who survived the scrutiny of the White House, sometimes at great personal cost, while supporting their families and famous husbands -- and sometimes changing history. Complete with illustrations and essential biographical details, it is an illuminating, entertaining, and ultimately inspiring read.
Biomarkers are of critical medical importance for oncologists, allowing them to predict and detect disease and to determine the best course of action for cancer patient care. Prognostic markers are used to evaluate a patient’s outcome and cancer recurrence probability after initial interventions such as surgery or drug treatments and, hence, to select follow-up and further treatment strategies. On the other hand, predictive markers are increasingly being used to evaluate the probability of benefit from clinical intervention(s), driving personalized medicine. Evolving technologies and the increasing availability of “multiomics” data are leading to the selection of numerous potential biomarkers, based on DNA, RNA, miRNA, protein, and metabolic alterations within cancer cells or tumor microenvironment, that may be combined with clinical and pathological data to greatly improve the prediction of both cancer progression and therapeutic treatment responses. However, in recent years, few biomarkers have progressed from discovery to become validated tools to be used in clinical practice. This Special Issue comprises eight review articles and five original studies on novel potential prognostic and predictive markers for different cancer types.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.